Advertisement
Canada markets closed
  • S&P/TSX

    23,475.14
    +263.97 (+1.14%)
     
  • S&P 500

    5,595.76
    +41.63 (+0.75%)
     
  • DOW

    41,096.77
    +235.06 (+0.58%)
     
  • CAD/USD

    0.7370
    +0.0006 (+0.08%)
     
  • CRUDE OIL

    69.45
    +0.48 (+0.70%)
     
  • Bitcoin CAD

    78,661.84
    +417.14 (+0.53%)
     
  • XRP CAD

    0.76
    +0.03 (+3.92%)
     
  • GOLD FUTURES

    2,589.60
    +9.00 (+0.35%)
     
  • RUSSELL 2000

    2,129.43
    +25.58 (+1.22%)
     
  • 10-Yr Bond

    3.6800
    +0.0270 (+0.74%)
     
  • NASDAQ futures

    19,446.75
    -0.50 (-0.00%)
     
  • VOLATILITY

    17.07
    -0.62 (-3.50%)
     
  • FTSE

    8,240.97
    +47.03 (+0.57%)
     
  • NIKKEI 225

    36,686.41
    -146.86 (-0.40%)
     
  • CAD/EUR

    0.6646
    -0.0001 (-0.02%)
     

Harvard Bioscience: Q2 Earnings Snapshot

HOLLISTON, Mass. (AP) — HOLLISTON, Mass. (AP) — Harvard Bioscience Inc. (HBIO) on Thursday reported a loss of $2.9 million in its second quarter.

On a per-share basis, the Holliston, Massachusetts-based company said it had a loss of 7 cents. Earnings, adjusted for one-time gains and costs, came to less than 1 cent on a per-share basis.

The medical instruments maker posted revenue of $23.1 million in the period.

Harvard Bioscience expects full-year revenue in the range of $97 million to $102 million.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on HBIO at https://www.zacks.com/ap/HBIO